Altre lingue Surgical Science Sweden AB

Azioni

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 18:00:00 12/07/2024			Variaz. 5gg	Var. 1 gen.
130,5 ^SEK	+1,64%		+1,40%	-28,49%

01/07	Surgical Science Sweden AB (publ) nomina Tom Englund come nuovo CEO, a partire dal 1° ottobre 2024	CI
15/05	Surgical Science Sweden AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Tom Englund appointed new CEO of Surgical Science	01/07
Surgical Science Sweden AB Appoints Tom Englund as New CEO, Effective October 1, 2024	01/07
Report from the Annual General Meeting of Surgical Science Sweden AB (publ)	16/05
Interim report January – March 2024: PROPRIETARY SIMULATORS WEAK, INDUSTRIAL SEGMENT STRONG	15/05
Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Conference call regarding interim report Q1	02/05
Notice of annual general meeting in SURGICAL SCIENCE SWEDEN AB (publ)	15/04
Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB	15/04
Gisli Hennermark to be nominated to Surgical Science's board	12/04
Surgical Science Sweden to Step Down; Search for Successor Starts	12/03
CEO Gisli Hennermark will leave Surgical Science in March 2025	12/03
Gisli Hennermark Intends to Leave as CEO of Surgical Science Sweden AB	12/03
Surgical Science Sweden Q4 2023 - Long-term high quality, short-term black box	22/02
Year-end report 2023: STRONG LICENSE REVENUE, WEAKER SIMULATOR SALES	21/02
Surgical Science Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21/02
Conference call regarding Year-end Report 2023	12/02
Exercise of options against Surgical Science's two largest shareholders	15/01
Global markets live: J Sainsbury, Intel, Tesla, Boeing, Amazon...	10/01
In wait-and-see mode	10/01
Surgical Science changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11

Non ci sono risultati per questa ricerca